📰 Mouse Models News
Page 3 - Mouse Models News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mouse Models. Real-time updates on events, politics, business and more.
April 14, 2023
Novocure today announced 27 presentations on Tumor Treating Fields will be delivered at the American Association for Cancer Research Annual Meeting 2023, to be held April 14 to 19 in Orlando,... | April 14, 2023
April 10, 2023
According to a study published in Science Translational Medicine, enhancing the regenerative capacity of adult tissues could improve wound healing and resistance to chronic degenerative diseases. The study involves research in large animals and mouse models and has found a breakthrough with an amino acid offering an enticing target for new therapies aimed at suppressing inflammation or accelerating the healing of skin wounds. , Health News, Times Now
December 6, 2022
/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage oncology company today announced preliminary results from the KRYSTAL-7 Phase 2...
December 5, 2022
/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage oncology company today announced preliminary results from the KRYSTAL-7 Phase 2...
November 3, 2022
Scientists have discovered how cancer cells exposed to high viscosity environments change their movements to improve their invasiveness and favor metastases.
November 2, 2022
Find out how the Diversity Outbred mouse platform from The Jackson Laboratory is increasing studies genetic diversity
August 15, 2022
The University of California, Davis, has been awarded just over $12 million from the National Institutes of Health under the third and final five-year phase of the Knockout Mouse Phenotyping Project, or KOMP2. UC Davis is the lead organization in a consortium involving a partnership with The Centre for Phenogenomics in Toronto.
July 8, 2022
University of New Orleans psychology professor Christopher Harshaw has been awarded a three-year grant to research the nature of social hyperthermia using mouse models of ASD.
June 8, 2022
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that data from Enanta's
June 8, 2022
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that data from Enanta’s internal development program portfolio for hepatitis B virus (HBV) and its...